Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunityTim Bognàr, Imke H. Bartelink, Layne Oram et al.|Blood Advances|2024Cited by 13
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM TrialAdriana Balduzzi, Marianne Ifversen, Evgenia Glogova et al.|Haematologica|2025Cited by 5
Total Body Irradiation Versus Chemotherapy Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphoblastic Leukemia Patients Aged 2 to 4 Years: A Retrospective Study of the EBMT Pediatric Diseases Working PartyAnna Eichinger, Krzysztof Kałwak, Zofia Szmit et al.|Blood|2024Cited by 1